17-74230938-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032646.6(TTYH2):c.353C>T(p.Ala118Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,614,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_032646.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTYH2 | NM_032646.6 | c.353C>T | p.Ala118Val | missense_variant | 3/14 | ENST00000269346.9 | NP_116035.5 | |
TTYH2 | NM_001330453.2 | c.290C>T | p.Ala97Val | missense_variant | 3/14 | NP_001317382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTYH2 | ENST00000269346.9 | c.353C>T | p.Ala118Val | missense_variant | 3/14 | 1 | NM_032646.6 | ENSP00000269346 | P1 | |
TTYH2 | ENST00000529107.5 | c.290C>T | p.Ala97Val | missense_variant | 3/14 | 2 | ENSP00000433089 | |||
TTYH2 | ENST00000578825.5 | n.65C>T | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251466Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135912
GnomAD4 exome AF: 0.000145 AC: 212AN: 1461852Hom.: 0 Cov.: 30 AF XY: 0.000133 AC XY: 97AN XY: 727232
GnomAD4 genome AF: 0.000118 AC: 18AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74360
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at